Ikena Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ikena Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Ikena Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.02M, a 49.1% decline year-over-year.
  • Ikena Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.05M, a 21.8% decline year-over-year.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.63M, a 1.42% increase from 2022.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.53M, a 45.4% increase from 2021.
  • Ikena Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.18M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.05M $1.02M -$981K -49.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.03M $1.28M -$600K -31.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.63M $2M +$1K +0.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $7.63M $1.76M -$104K -5.59% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $7.74M $2M +$187K +10.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $7.55M $1.88M -$76K -3.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.63M $2M +$100K +5.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $7.53M $1.86M +$278K +17.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $7.25M $1.81M +$362K +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.89M $1.96M +$693K +54.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.19M $1.9M +$1.02M +115% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.18M $1.58M +$931K +143% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $4.25M $1.45M +$1.03M +247% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $3.22M $1.26M +$908K +256% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.31M $885K +$510K +136% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.8M $650K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $418K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $354K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $375K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.